The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of KRAS on outcomes of patients with unresectable colorectal liver metastases (CRLM).
Celina Ang
No relevant relationships to disclose
Alexandra N. Gewirtz
No relevant relationships to disclose
Joanne F. Chou
No relevant relationships to disclose
Marinela Capanu
No relevant relationships to disclose
Efsevia Vakiani
No relevant relationships to disclose
Nancy E. Kemeny
No relevant relationships to disclose